<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Atara Biotherapeutics, Inc. (ATRA) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/atra/filings</link>
    <description>Latest company filings for Atara Biotherapeutics, Inc. (ATRA) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Mon, 13 Jul 2026 08:12:02 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/atra/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826002571/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002571</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826002570/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-002570</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826002507/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000905148-26-002507</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider sale notice (144) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826002506/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000905148-26-002506</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider sale notice (144) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ATRA: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000110465926061506/xslSCHEDULE_13D_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-061506</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-05-14.]]></description>
      <pubDate>Thu, 14 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[ATRA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000091957426002914/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000919574-26-002914</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526219518/atra-424-b5-2026_q2.htm</link>
      <guid isPermaLink="false">0001193125-26-219518</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526219482/atra-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-219482</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526219420/atra-20260512.htm</link>
      <guid isPermaLink="false">0001193125-26-219420</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Major company event (8-K) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526217389/xslSCHEDULE_13D_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-217389</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526217380/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-217380</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000093583626000239/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0000935836-26-000239</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000093583626000238/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0000935836-26-000238</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a New insider ownership (3) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[ATRA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000091957426002802/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000919574-26-002802</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-08.]]></description>
      <pubDate>Fri, 08 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526212781/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-212781</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider sale notice (144) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526210413/atra-20260507.htm</link>
      <guid isPermaLink="false">0001193125-26-210413</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Major company event (8-K) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000093583626000230/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000935836-26-000230</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526201397/atra-20260430.htm</link>
      <guid isPermaLink="false">0001193125-26-201397</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Major company event (8-K) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526177285/atra-20260424.htm</link>
      <guid isPermaLink="false">0001193125-26-177285</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-24.]]></description>
      <pubDate>Fri, 24 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526177280/atra-2026-defa14a.htm</link>
      <guid isPermaLink="false">0001193125-26-177280</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-24.]]></description>
      <pubDate>Fri, 24 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[ATRA: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/999999999526000930/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-000930</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a EFFECT (EFFECT) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[ATRA: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526124322/d100379d424b3.htm</link>
      <guid isPermaLink="false">0001193125-26-124322</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a 424B3 (424B3) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Company correspondence (CORRESP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526119715/filename1.htm</link>
      <guid isPermaLink="false">0001193125-26-119715</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Company correspondence (CORRESP) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>CORRESP</category>
    </item>
    <item>
      <title><![CDATA[ATRA: SEC correspondence (UPLOAD)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000000000026002840/filename1.pdf</link>
      <guid isPermaLink="false">0000000000-26-002840</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a SEC correspondence (UPLOAD) on 2026-03-20.]]></description>
      <pubDate>Fri, 20 Mar 2026 12:00:00 GMT</pubDate>
      <category>UPLOAD</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526116060/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-116060</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-03-19.]]></description>
      <pubDate>Thu, 19 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Securities registration (S-3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526110849/d100379ds3.htm</link>
      <guid isPermaLink="false">0001193125-26-110849</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Securities registration (S-3) on 2026-03-17.]]></description>
      <pubDate>Tue, 17 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-3</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526108386/atra-424-b5-2026_q1.htm</link>
      <guid isPermaLink="false">0001193125-26-108386</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526108361/atra-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-108361</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Annual report (10-K) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526108344/atra-20260316.htm</link>
      <guid isPermaLink="false">0001193125-26-108344</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Major company event (8-K) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526103127/atra-20260312.htm</link>
      <guid isPermaLink="false">0001193125-26-103127</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Major company event (8-K) on 2026-03-12.]]></description>
      <pubDate>Thu, 12 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826001225/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001225</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-03-11.]]></description>
      <pubDate>Wed, 11 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826001224/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001224</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-03-11.]]></description>
      <pubDate>Wed, 11 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826001144/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001144</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826001143/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-26-001143</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526086793/d121575d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-086793</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Major company event (8-K) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826001102/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000905148-26-001102</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514826001100/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000905148-26-001100</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526062534/d105335d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-062534</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Major company event (8-K) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526013362/xslSCHEDULE_13D_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-013362</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-01-14.]]></description>
      <pubDate>Wed, 14 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526013358/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-013358</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2026-01-14.]]></description>
      <pubDate>Wed, 14 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526010883/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001193125-26-010883</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider sale notice (144) on 2026-01-12.]]></description>
      <pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526010342/d34257d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-010342</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Major company event (8-K) on 2026-01-12.]]></description>
      <pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312526000907/d90230d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-000907</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Major company event (8-K) on 2026-01-02.]]></description>
      <pubDate>Fri, 02 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000119312525304018/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-25-304018</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2025-12-01.]]></description>
      <pubDate>Mon, 01 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514825004141/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-25-004141</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2025-11-19.]]></description>
      <pubDate>Wed, 19 Nov 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514825004140/xslF345X05/form4.xml</link>
      <guid isPermaLink="false">0000905148-25-004140</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider trade (4) on 2025-11-19.]]></description>
      <pubDate>Wed, 19 Nov 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514825004102/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000905148-25-004102</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider sale notice (144) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ATRA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000090514825004101/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000905148-25-004101</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a Insider sale notice (144) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ATRA: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000110465925112574/xslSCHEDULE_13D_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-25-112574</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2025-11-14.]]></description>
      <pubDate>Fri, 14 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[ATRA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1604464/000093583625000703/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000935836-25-000703</guid>
      <description><![CDATA[Atara Biotherapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-11-14.]]></description>
      <pubDate>Fri, 14 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
  </channel>
</rss>